On May 23, 2021, the board of directors of Adamis Pharmaceuticals Corporation designated and appointed David C. Benedicto, the company's senior director of accounting and controller, as the company's principal accounting officer; previously, Robert O. Hopkins, the company's chief financial officer, served as the company's principal accounting officer. Mr. Benedicto, 60, joined the Company in December 2014, as accounting manager. Mr. Benedicto, a CPA and CMA (Certified Management Accountant), earned a Bachelor's degree in Commerce from the University of Saint La Salle, and an M.B.A. from the University of the Redlands. The selection of Mr. Benedicto to serve as principal accounting officer was not made pursuant to any arrangement or understanding with any other person. The Company will enter into the Company's form of indemnity agreement with Mr. Benedicto.